The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5p

(1) Background: MicroRNAs are involved in the expression of the gene encoding the chloride channel CFTR (Cystic Fibrosis Transmembrane Conductance Regulator); the objective of this short report is to study the effects of the treatment of bronchial epithelial Calu-3 cells with molecules mimicking the activity of pre-miR-145-5p, pre-miR-335-5p, and pre-miR-101-3p, and to discuss possible translational applications of these molecules in pre-clinical studies focusing on the development of protocols of possible interest in therapy; (2) Methods: CFTR mRNA was quantified by Reverse Transcription quantitative Polymerase Chain Reaction (RT-qPCR). The production of the CFTR protein was assessed by Western blotting; (3) Results: The treatment of Calu-3 cells with agomiR-145-5p caused the highest inhibition of CFTR mRNA accumulation and CFTR production; (4) Conclusions: The treatment of target cells with the agomiR pre-miR-145-5p should be considered when CFTR gene expression should be inhibited in pathological conditions, such as polycystic kidney disease (PKD), some types of cancer, cholera, and SARS-CoV-2 infection.

[1]  G. Lippi,et al.  SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation , 2023, Nature Communications.

[2]  P. Hegyi,et al.  CFTR-beyond the airways: Recent findings on the role of the CFTR channel in the pancreas, the intestine and the kidneys. , 2023, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  D. Tanramluk,et al.  Vasoactive intestinal peptide and cystic fibrosis transmembrane conductance regulator contribute to the transepithelial calcium transport across intestinal epithelium-like Caco-2 monolayer , 2022, PloS one.

[4]  Zhi-bin Yang,et al.  mir-145-5p is a suppressor of colorectal cancer at early stage, while promotes colorectal cancer metastasis at late stage through regulating AKT signaling evoked EMT-mediated anoikis , 2022, BMC Cancer.

[5]  R. Gambari,et al.  Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene , 2022, International journal of molecular sciences.

[6]  A. Sbarbati,et al.  CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells , 2022, Cells.

[7]  J. Mekalanos,et al.  A Potent Inhibitor of the Cystic Fibrosis Transmembrane Conductance Regulator Blocks Disease and Morbidity Due to Toxigenic Vibrio cholerae , 2022, Toxins.

[8]  Majed El-Dweik,et al.  A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time , 2022, Pathogens.

[9]  S. Soodvilai,et al.  Pinostrobin inhibits renal CFTR-mediated Cl- secretion and retards cyst growth in cell-derived cyst and polycystic kidney disease rats. , 2022, Journal of pharmacological sciences.

[10]  A. Al Khal,et al.  SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity , 2021, Vaccines.

[11]  W. Chavasiri,et al.  A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease , 2021, Clinical and Experimental Nephrology.

[12]  R. Gambari,et al.  A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 , 2021, Biomedicines.

[13]  R. Gambari,et al.  Differential effects on the miRNome of the treatment of human airway epithelial Calu-3 cells with peptide-nucleic acids (PNAs) targeting microRNAs miR-101-3p and miR-145-5p: Next generation sequencing datasets , 2021, Data in brief.

[14]  Huaqin Sun,et al.  High cystic fibrosis transmembrane conductance regulator expression in childhood B-cell acute lymphoblastic leukemia acts as a potential therapeutic target , 2021, Translational cancer research.

[15]  H. D. de Jonge,et al.  Strategies for cystic fibrosis transmembrane conductance regulator inhibition: from molecular mechanisms to treatment for secretory diarrhoeas , 2020, FEBS letters.

[16]  Ke Peng,et al.  MicroRNA-145-5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells , 2020, Molecular medicine reports.

[17]  R. Gambari,et al.  Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene. , 2020, European journal of medicinal chemistry.

[18]  Ashish Ranjan Sharma,et al.  Therapeutic advances of miRNAs: A preclinical and clinical update , 2020, Journal of advanced research.

[19]  V. Bezzerri,et al.  Does cystic fibrosis constitute an advantage in COVID-19 infection? , 2020, Italian Journal of Pediatrics.

[20]  Can Liu,et al.  CFTR Functions as a Tumor Suppressor and Is Regulated by DNA Methylation in Colorectal Cancer , 2020, Cancer management and research.

[21]  H. Feng,et al.  CFTR promotes malignant glioma development via up‐regulation of Akt/Bcl2‐mediated anti‐apoptosis pathway , 2020, Journal of cellular and molecular medicine.

[22]  G. Valacchi,et al.  Particulate Matter Decreases Intestinal Barrier-Associated Proteins Levels in 3D Human Intestinal Model , 2020, International journal of environmental research and public health.

[23]  Gates B. Colbert,et al.  Update and review of adult polycystic kidney disease. , 2020, Disease-a-month : DM.

[24]  R. Gambari,et al.  A Peptide Nucleic Acid (PNA) Masking the miR-145-5p Binding Site of the 3′UTR of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) mRNA Enhances CFTR Expression in Calu-3 Cells , 2020, Molecules.

[25]  M. Tao,et al.  miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA3. , 2020, Pathology, research and practice.

[26]  Fangping Mu,et al.  Precise Targeting of miRNA Sites Restores CFTR Activity in CF Bronchial Epithelial Cells. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  R. Gambari,et al.  Efficient Delivery of MicroRNA and AntimiRNA Molecules Using an Argininocalix[4]arene Macrocycle , 2019, Molecular therapy. Nucleic acids.

[28]  R. Gambari,et al.  Enhancing the Expression of CFTR Using Antisense Molecules against MicroRNA miR-145-5p , 2019, American journal of respiratory and critical care medicine.

[29]  J. Kocerha,et al.  The Potential for microRNA Therapeutics and Clinical Research , 2019, Front. Genet..

[30]  A. Mishra,et al.  MicroRNAs in Cutaneous T-Cell Lymphoma: The Future of Therapy. , 2019, The Journal of investigative dermatology.

[31]  R. Dutta,et al.  A Neutralizing Aptamer to TGFBR2 and miR-145 Antagonism Rescue Cigarette Smoke- and TGF-β-Mediated CFTR Expression , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  G. Petsko,et al.  Cholera toxin inhibits SNX27-retromer-mediated delivery of cargo proteins to the plasma membrane , 2018, Journal of Cell Science.

[33]  S. Hannongbua,et al.  A fungal metabolite zearalenone as a CFTR inhibitor and potential therapy of secretory diarrheas , 2018, Biochemical pharmacology.

[34]  R. Gambari,et al.  A Peptide Nucleic Acid against MicroRNA miR-145-5p Enhances the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in Calu-3 Cells , 2017, Molecules.

[35]  W. T. Harris,et al.  MicroRNA‐145 Antagonism Reverses TGF‐&bgr; Inhibition of F508del CFTR Correction in Airway Epithelia , 2017, American journal of respiratory and critical care medicine.

[36]  V. Chatsudthipong,et al.  Steviol stabilizes polycystin 1 expression and promotes lysosomal degradation of CFTR and β-catenin proteins in renal epithelial cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[37]  A. Pavlícek,et al.  Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial , 2017, The Lancet.

[38]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[39]  C. Hodges,et al.  CFTR is a tumor suppressor gene in murine and human intestinal cancer , 2016, Oncogene.

[40]  P. Srimanote,et al.  Pathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice. , 2016, Virulence.

[41]  Vikas Gupta,et al.  MicroRNA therapeutics: Discovering novel targets and developing specific therapy , 2016, Perspectives in clinical research.

[42]  Jia Li,et al.  High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo. , 2015, Oncology reports.

[43]  T. Ghosh,et al.  Insights into the miRNA regulations in human disease genes , 2014, BMC Genomics.

[44]  L. van Doorn,et al.  In Vitro Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122 , 2014, Antimicrobial Agents and Chemotherapy.

[45]  Ashley M. Jacobi,et al.  Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. , 2013, American journal of respiratory cell and molecular biology.

[46]  I. Oglesby,et al.  Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by MicroRNA-145, -223, and -494 Is Altered in ΔF508 Cystic Fibrosis Airway Epithelium , 2013, The Journal of Immunology.

[47]  G. Nuovo,et al.  MiR-101 and miR-144 Regulate the Expression of the CFTR Chloride Channel in the Lung , 2012, PloS one.

[48]  Yu Li,et al.  MicroRNAs in Common Human Diseases , 2012, Genom. Proteom. Bioinform..

[49]  S. Soodvilai,et al.  Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera , 2012, Indian journal of pharmacology.

[50]  Ashley M. Jacobi,et al.  A microRNA network regulates expression and biosynthesis of wild-type and ΔF508 mutant cystic fibrosis transmembrane conductance regulator , 2012, Proceedings of the National Academy of Sciences.

[51]  S. Cialfi,et al.  Synergistic Post-Transcriptional Regulation of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) by miR-101 and miR-494 Specific Binding , 2011, PloS one.

[52]  Austin E. Gillen,et al.  MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. , 2011, The Biochemical journal.

[53]  T. Shaffer,et al.  Cultured Human Airway Epithelial Cells (Calu-3): A Model of Human Respiratory Function, Structure, and Inflammatory Responses , 2010, Critical care research and practice.

[54]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[55]  A S Verkman,et al.  Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.

[56]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[57]  Richard W. Carthew,et al.  Silence from within: Endogenous siRNAs and miRNAs , 2005, Cell.

[58]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[59]  L. Rome,et al.  The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. , 1996, Kidney international.